Sponsor:
University of Colorado, Denver
Code:
NCT07252050
Conditions
Sickle Cell Disease
Hematopoetic Stem Cell Transplant
Haploidentical Hematopoietic Stem Cell Transplant
Haploidentical Stem Cell Transplantation
Graft Failure
Eligibility Criteria
Sex: All
Age: 12 - 45
Healthy Volunteers: Not accepted
Interventions
Ruxolitinib
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-05-18. This information was provided to ClinicalTrials.gov by University of Colorado, Denver on 2026-05-15.